Skip to main content
Contacts
Locations and phones

Call center 93 253 21 00

Monday to Sunday, from 8 a.m. to 8:30 p.m.

Private Care - International Patients +34 93 600 97 83

Monday to Friday, from 8 a.m. to 7 p.m.

SJD Barcelona Children´s Hospital

Passeig Sant Joan de Déu, 2, 08950 Esplugues de Llobregat

How to arrive

Language -

Leukaemia is the most common cancer in childhood. It occurs when white blood cells transform into malignant or cancerous cells.

Treatment of leukaemia in Spain

SJD Barcelona Children's Hospital belongs to Innovative Therapies for Children with Cancer (ITCC), which allows us to access the most innovative treatments and include our patients in pioneering clinical trials. An example of new treatments is the application of CAR-T 19 immunotherapy: we are one of the few pediatric centers in Europe and the only one in Spain that offers this therapy. 

Currently, CAR-T 19 immunotherapy treatment is offered in patients who have undergone conventional treatments without success, usually with one or more relapses.

Why SJD Barcelona Children's Hospital?

A national reference centre

The SJD Barcelona Children's Hospital's Oncology and Haematology Department is the national reference centre of for the treatment of developmental cancer and an international reference centre for determined types of tumours.

Outcomes

84
%

Acute lymphoblastic leukaemia patients, survival rate at five years

Research

The SJD Barcelona Children's Hospital investigates the main types of childhood leukaemia that affect our patients. The objective of our research groups on pediatric leukaemia is to deepen our knowledge of the origin and molecular basis of this type of cancer to achieve new tools for diagnosis, prognosis and treatment.